1-13 of 13
C Koller
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Combined Cyclophosphamide, Fludarabine, Alemtuzumab, and Rituximab (CFAR), an Active Frontline Regimen for High-Risk Patients with CLL.

William G. Wierda, MD, PhD, S. O’Brien, MD, A. Ferrajoli, MD, S. Faderl, MD, C. Koller, MD, Z. Estrov, MD, G. Garcia-Manero, MD, S. Verstovsek, MD, M. Browning, BSN, ADN, S. Lerner, MS, BA, M. Keating, MB, BS
Journal: Blood
Blood (2007) 110 (11): 628.
https://doi.org/10.1182/blood.V110.11.628.628
Published: 2007
Journal Articles

Serum Beta-2 Microglobulin: The Universal Independent Prognostic Factor for Patients with CLL.

William G. Wierda, MD, PhD, X. Wang, MS, S. OBrien, MD, S. Faderl, MD, A. Ferrajoli, MD, D. Thomas, MD, F. Ravandi, MD, J. Cortes, MD, F. Giles, MD, C. Koller, MD, H. Kantarjian, MD, S. Lerner, MS, M. Keating, MB BS
Journal: Blood
Blood (2005) 106 (11): 5018.
https://doi.org/10.1182/blood.V106.11.5018.5018
Published: 2005
Journal Articles

Salvage Therapy with Combined Cyclophosphamide (C), Fludarabine (F), Alemtuzumab (A), and Rituximab (R) (CFAR) for Heavily Pre-Treated Patients with CLL.

William G. Wierda, MD, PhD, S. OBrien, MD, A. Ferrajoli, MD, S. Faderl, MD, C. Koller, MD, F. Giles, MD, J. Cortes, MD, D. Thomas, MD, F. Ravandi, MD, G. Garcia-Manero, MD, M. Andreeff, MD, S. Lerner, MS, H. Kantarjian, MD, M. Keating, MD
Journal: Blood
Blood (2005) 106 (11): 719.
https://doi.org/10.1182/blood.V106.11.719.719
Published: 2005
Journal Articles

Long-Term Follow-Up of Patients With Chronic Lymphocytic Leukemia (CLL) Receiving Fludarabine Regimens as Initial Therapy

M.J. Keating, S. O’Brien, S. Lerner, C. Koller, M. Beran, L.E. Robertson, E. J Freireich, E. Estey, H. Kantarjian
Journal: Blood
Blood (1998) 92 (4): 1165–1171.
https://doi.org/10.1182/blood.V92.4.1165
Published: 1998
Journal Articles

Topotecan, a topoisomerase I inhibitor, is active in the treatment of myelodysplastic syndrome and chronic myelomonocytic leukemia

M Beran, H Kantarjian, S O'Brien, C Koller, M al-Bitar, S Arbuck, S Pierce, M Moore, JL Abbruzzese, M Andreeff, M Keating, E Estey
Journal: Blood
Blood (1996) 88 (7): 2473–2479.
https://doi.org/10.1182/blood.V88.7.2473.bloodjournal8872473
Published: 1996
Journal Articles

Homoharringtonine therapy induces responses in patients with chronic myelogenous leukemia in late chronic phase

S O'Brien, H Kantarjian, M Keating, M Beran, C Koller, LE Robertson, J Hester, MB Rios, M Andreeff, M Talpaz
Journal: Blood
Blood (1995) 86 (9): 3322–3326.
https://doi.org/10.1182/blood.V86.9.3322.bloodjournal8693322
Published: 1995
Journal Articles

Interferon maintenance therapy for patients with chronic lymphocytic leukemia in remission after fludarabine therapy

S O'Brien, H Kantarjian, M Beran, LE Robertson, C Koller, S Lerner, MJ Keating
Journal: Blood
Blood (1995) 86 (4): 1298–1300.
https://doi.org/10.1182/blood.V86.4.1298.bloodjournal8641298
Published: 1995
Journal Articles

Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment [see comments]

S O'Brien, H Kantarjian, M Beran, T Smith, C Koller, E Estey, LE Robertson, S Lerner, M Keating
Journal: Blood
Blood (1993) 82 (6): 1695–1700.
https://doi.org/10.1182/blood.V82.6.1695.1695
Published: 1993
Journal Articles

Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent

MJ Keating, S O'Brien, H Kantarjian, W Plunkett, E Estey, C Koller, M Beran, EJ Freireich
Journal: Blood
Blood (1993) 81 (11): 2878–2884.
https://doi.org/10.1182/blood.V81.11.2878.2878
Published: 1993
Journal Articles

Phase I study of Topotecan, a new topoisomerase I inhibitor, in patients with refractory or relapsed acute leukemia

HM Kantarjian, M Beran, A Ellis, L Zwelling, S O'Brien, L Cazenave, C Koller, MB Rios, W Plunkett, MJ Keating
Journal: Blood
Blood (1993) 81 (5): 1146–1151.
https://doi.org/10.1182/blood.V81.5.1146.1146
Published: 1993
Journal Articles

Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA)

EH Estey, R Kurzrock, HM Kantarjian, SM O'Brien, KB McCredie, M Beran, C Koller, MJ Keating, C Hirsch-Ginsberg, YO Huh
Journal: Blood
Blood (1992) 79 (4): 882–887.
https://doi.org/10.1182/blood.V79.4.882.882
Published: 1992
Journal Articles

Fludarabine: a new agent with major activity against chronic lymphocytic leukemia

MJ Keating, H Kantarjian, M Talpaz, J Redman, C Koller, B Barlogie, W Velasquez, W Plunkett, EJ Freireich, KB McCredie
Journal: Blood
Blood (1989) 74 (1): 19–25.
https://doi.org/10.1182/blood.V74.1.19.19
Published: 1989
Journal Articles

Detection of leukemic clone maturation in vivo by premature chromosome condensation

WN Hittelman, P Agbor, I Petkovic, B Andersson, H Kantarjian, R Walters, C Koller, M Beran
Journal: Blood
Blood (1988) 72 (6): 1950–1960.
https://doi.org/10.1182/blood.V72.6.1950.1950
Published: 1988